Enhancing Kidney Donation Through Live Organ Video Educated Donors (LOVED) Study Phase
LOVED
1 other identifier
interventional
54
1 country
1
Brief Summary
LOVED stands for the Living Organ Video Educated Donors (LOVED) program. It is a culturally tailored program for African Americans to reduce the disparity of low rates of living kidney donation. It is a mobile health delivered platform that does not require transplant center visits, thus increasing the reach of the program compared to center-based program to enhance living kidney donation. The purpose of LOVED is to give education and encouragement to those who need a kidney transplant and teach about the process of living donation to be better educated when approaching others about donating a kidney. The ultimate goal of the program is to increase the number of living kidney donor transplants, especially among African Americans in South Carolina. The program was created to educate those in need of a kidney about the donor process, to dispel myths about living donation, discuss who can be asked to donate and develop and practice skills to start asking others for a living kidney donation. The program is designed to be completed using a tablet computer and is made up of weekly video education clips, resources, short quizzes to reinforce the learning points and weekly video chat sessions with others who need a kidney led by a "navigator" who was once a living donor kidney recipient. The video clips are made up of stories and brief educational messages from transplant center staff, physicians, former donors and recipients. The video chat sessions were designed to solve and address individual issues for those enrolled in the program and to give a sense of community as they continue on their journey to find a kidney. This randomized control trial uses groups of 6-9 participants in each LOVED group that lasts 8-weeks each. A total of 60 participants will be recruited with 30 assigned to LOVED and 30 assigned to a standard care groups. This program is funded by a grant from the National Institute of Health and was developed at the Medical University of South Carolina.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2016
CompletedFirst Submitted
Initial submission to the registry
December 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2018
CompletedFirst Posted
Study publicly available on registry
July 26, 2018
CompletedMay 18, 2021
May 1, 2021
8 months
December 1, 2016
May 14, 2021
Conditions
Outcome Measures
Primary Outcomes (4)
Participant adherence to study protocols
Tolerability as defined by % retention to study (% of participants who self-remove from the study) Fidelity as defined by %adherence to chat sessions and completion %of video modules.
Assessed at 8 weeks
Change in knowledge about living donation
Score measures for self-efficacy, knowledge and attitudes to approach others to be a living donor -LDKT Knowledge Scale (knowledge) (15 item T/F); each correct response adds 1 point. 0-15 range with higher numbers represent higher knowledge.
Change between 0 and 8 weeks and change between 0 and 6 months
Change in attitudes on living donation
LDKT Concerns Scale (i.e., measuring attitudes) (21 T/F with one point for each statement suggestive of more worry); 0-21 range with higher results representing more concerns about LDKT.
Change between 0 and 8 weeks and change between 0 and 6 months
Change in self-efficacy to ask others to be a living donor
Willingness to Discuss LDKT Scale (i.e., measuring self-efficacy (SE)) (1 item each for family, friends, and strangers7 pt. Likert scale) 1-7 range with higher values representing higher SE to approach others about living donation
Change between 0 and 8 weeks and change between 0 and 6 months
Secondary Outcomes (1)
Completing living donor kidney transplantation
8 weeks, 6 months
Other Outcomes (4)
Assessment of making autonomous decisions
8 weeks
Assessment of feelings of trust
8 weeks
Assessment of cultural competency
8 weeks
- +1 more other outcomes
Study Arms (2)
LOVED intervention
EXPERIMENTALIntervention group receives the LOVED program, an 8-week program where participants receive video education modules, and weekly video chat sessions with other end-stage renal disease patients and a prior living kidney African American recipient. The program aims to increase knowledge and skills on how to promote individual strategies on how to ask for a kidney from others.
Standard Care
NO INTERVENTIONStandard interaction with transplant center and physician care.
Interventions
Eligibility Criteria
You may qualify if:
- years old
- African American
- Legally competent
- Able to read and speak in English
- Able to use tablet computers (after instruction)
- Able to use cell phone
- years or less on the kidney waitlist with active status including pre-emptive and ESRD patients on dialysis
- years or less on dialysis
You may not qualify if:
- Patients who have currently identified PDs moving through the evaluation stage
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Frank A Treiber, PhD
Medical University of South Carolina
- PRINCIPAL INVESTIGATOR
Baliga Baliga, MD
Medical University of South Carolina
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 1, 2016
First Posted
July 26, 2018
Study Start
August 1, 2016
Primary Completion
April 1, 2017
Study Completion
February 1, 2018
Last Updated
May 18, 2021
Record last verified: 2021-05
Data Sharing
- IPD Sharing
- Will not share